Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07455864) titled 'Lysosomal Acid Lipase Deficiency in Risk Groups' on March 3.

Study Type: Observational

Primary Sponsor: AstraZeneca

Condition: Lysosomal Acid Lipase Deficiency

Recruitment Status: Recruiting

Date of First Enrollment: February 25, 2026

Target Sample Size: 1200

Countries of Recruitment: Russia

To know more, visit https://clinicaltrials.gov/study/NCT07455864

Published by HT Digital Content Services with permission from Health Daily Digest....